Skip to content

Associations between Adolescent Cannabis Use and Brain Structure in Psychosis

H. Abush, S. Ghose, Erin van Enkevort, Brett Clementz, Godfrey D Pearlson, John A. Sweeney, Matcheri S Keshavan, Carol A. Tamminga, Elena Ivleva

Psychiatry Research Neuroimaging March 28, 2018 DOI: 10.1016/j.pscychresns.2018.03.008 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional neuroimaging study Peer reviewed
Sample size 109
Population Individuals with psychotic disorders (schizophrenia or bipolar I disorder), stratified by history of adolescent cannabis use, and healthy controls
Measures Voxel Based Morphometry (VBM)
Topics Cannabis
Key findings Psychosis patients with a history of adolescent cannabis use showed less pronounced gray matter density reductions than non-users, especially in schizophrenia, where GMD in users did not differ from healthy controls without cannabis use. The authors indicate that adolescent cannabis use is associated with attenuated GMD abnormalities in psychotic individuals.

Abstract

Associations between cannabis use and psychotic disorders suggest that cannabis may be a contributory risk factor in the neurobiology of psychosis. In this study, we examined brain structure characteristics, total and regional gray matter density (GMD), using Voxel Based Morphometry, in psychotic individuals, stratified by history of cannabis use (total n=109). We also contrasted GMD estimates in individual diagnostic groups (schizophrenia/bipolar I disorder) with and without history of adolescent cannabis use (ACU). Individuals with psychosis as a whole, both with and without history of ACU, had lower total and regional GMD, compared to healthy controls. ACU was associated with attenuated GMD reductions, compared to non-users, especially in the schizophrenia cases, who showed robust GMD reductions in fronto-temporal and parietal cortex, as well as subcortical regions. Notably, total and regional GMD estimates in individuals with psychosis and ACU were not different from controls with no ACU. These data indicate that the history of ACU in psychotic individuals is associated with attenuated GMD abnormalities. Future investigations targeting potential unique etiological and risk factors associated with psychosis in individuals with ACU may help in understanding of the neurobiology of psychotic disorders and novel treatment options for these individuals.

Comparable studies

Other experimental studies on cannabis, most cited first.

Study Year Design Participants
Smoked Cannabis' Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers Occasional (<2x/week) and frequent (≥4x/week) cannabis smokers 2015 Controlled within-subjects study n = 25
Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity Healthy volunteers experienced with cannabis but not regular users 2019 Within-subjects experimental design n = 17
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Young cannabis users 2018 Observational study (naturalistic, within-subject counterbalanced design) n = 410
Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects Healthy volunteers 2018 Experimental study n = 5
Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis Patients with multiple sclerosis who began using cannabis after disease onset, used it... 2019 Quasi-experimental study with odd-even allocation n = 40

Citations in the library

Cited by 5

Cites 14

and 9 more in the library

Explore topics